Search

Gyounghyun Bae

Examiner (ID: 13117, Phone: (571)270-5942 , Office: P/3742 )

Most Active Art Unit
3742
Art Unit(s)
3761, 3742, 3724
Total Applications
566
Issued Applications
395
Pending Applications
1
Abandoned Applications
171

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17958617 [patent_doc_number] => 20220339197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => USE OF HEMATOPOIETIC STEM CELLS IN PREPARATION OF FORMULATION FOR TREATING VIRAL DISEASES [patent_app_type] => utility [patent_app_number] => 17/766071 [patent_app_country] => US [patent_app_date] => 2020-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766071 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/766071
USE OF HEMATOPOIETIC STEM CELLS IN PREPARATION OF FORMULATION FOR TREATING VIRAL DISEASES Oct 13, 2020 Abandoned
Array ( [id] => 18595997 [patent_doc_number] => 20230270788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/767453 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767453
COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF Oct 7, 2020 Abandoned
Array ( [id] => 17807827 [patent_doc_number] => 20220259662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON RENAL FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/765695 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5996 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765695 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765695
BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON RENAL FIBROSIS Sep 28, 2020 Pending
Array ( [id] => 17961334 [patent_doc_number] => 20220341915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => LUNG FIBROSIS MODEL AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/763991 [patent_app_country] => US [patent_app_date] => 2020-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763991 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763991
LUNG FIBROSIS MODEL AND METHODS OF USING THE SAME Sep 27, 2020 Pending
Array ( [id] => 17958621 [patent_doc_number] => 20220339201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE [patent_app_type] => utility [patent_app_number] => 17/753491 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -60 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753491
FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE Sep 8, 2020 Pending
Array ( [id] => 18005308 [patent_doc_number] => 20220364074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/634723 [patent_app_country] => US [patent_app_date] => 2020-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634723 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634723
RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE Aug 10, 2020 Pending
Array ( [id] => 17807729 [patent_doc_number] => 20220259564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => METHOD OF CULTURING MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/627500 [patent_app_country] => US [patent_app_date] => 2020-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12353 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/627500
METHOD OF CULTURING MESENCHYMAL STEM CELLS Jul 14, 2020 Abandoned
Array ( [id] => 20384869 [patent_doc_number] => 12484575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-02 [patent_title] => Mosquito egg cryopreservation [patent_app_type] => utility [patent_app_number] => 17/626381 [patent_app_country] => US [patent_app_date] => 2020-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 8316 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626381 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/626381
Mosquito egg cryopreservation Jul 12, 2020 Issued
Array ( [id] => 17988864 [patent_doc_number] => 20220354901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => METHODS OF FUNCTIONAL VASCULARIZATION OF PANCREATIC ISLETS AND BETA-CELL ORGANOIDS [patent_app_type] => utility [patent_app_number] => 17/623493 [patent_app_country] => US [patent_app_date] => 2020-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623493 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/623493
METHODS OF FUNCTIONAL VASCULARIZATION OF PANCREATIC ISLETS AND BETA-CELL ORGANOIDS Jul 1, 2020 Pending
Array ( [id] => 18297555 [patent_doc_number] => 20230107241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => ANTI-INFLAMMAATORY AND ANTI-VIRAL COMPOSITION BASED ON PLACENTA-DERIVED EXTRACELLULAR VESICLE [patent_app_type] => utility [patent_app_number] => 17/603459 [patent_app_country] => US [patent_app_date] => 2020-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8255 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603459 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/603459
ANTI-INFLAMMAATORY AND ANTI-VIRAL COMPOSITION BASED ON PLACENTA-DERIVED EXTRACELLULAR VESICLE Jun 24, 2020 Pending
Array ( [id] => 17759984 [patent_doc_number] => 20220233596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => Modified NK-92 cells, and therapeutic and diagnostic uses thereof [patent_app_type] => utility [patent_app_number] => 17/614900 [patent_app_country] => US [patent_app_date] => 2020-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/614900
Modified NK-92 cells, and therapeutic and diagnostic uses thereof Jun 8, 2020 Pending
Array ( [id] => 17928381 [patent_doc_number] => 20220323506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => Oligodendrocyte-derived Extracellular Vesicles for Therapy of Multiple Sclerosis [patent_app_type] => utility [patent_app_number] => 17/615975 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615975 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/615975
Oligodendrocyte-derived extracellular vesicles for therapy of multiple sclerosis Jun 2, 2020 Issued
Array ( [id] => 20402410 [patent_doc_number] => 12492380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Methods for the production of hepatocytes [patent_app_type] => utility [patent_app_number] => 17/610123 [patent_app_country] => US [patent_app_date] => 2020-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 46 [patent_no_of_words] => 14209 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610123 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/610123
Methods for the production of hepatocytes May 10, 2020 Issued
Array ( [id] => 19113139 [patent_doc_number] => 20240124889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION [patent_app_type] => utility [patent_app_number] => 17/609170 [patent_app_country] => US [patent_app_date] => 2020-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 355057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609170 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/609170
COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION May 6, 2020 Abandoned
Array ( [id] => 20025181 [patent_doc_number] => 20250163403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => METHOD OF INTRODUCING A PLURALITY OF GENE DRIVES INTO A POPULATION [patent_app_type] => utility [patent_app_number] => 17/607138 [patent_app_country] => US [patent_app_date] => 2020-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3621 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/607138
METHOD OF INTRODUCING A PLURALITY OF GENE DRIVES INTO A POPULATION Apr 30, 2020 Abandoned
Array ( [id] => 18309202 [patent_doc_number] => 20230113102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => ENGINEERED CRY PROTEINS FOR DELIVERY OF THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 17/602980 [patent_app_country] => US [patent_app_date] => 2020-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602980 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/602980
Engineered cry proteins for delivery of therapeutics Apr 14, 2020 Issued
Array ( [id] => 17734968 [patent_doc_number] => 20220220427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => CULTURE CONTAINER FOR CULTURING EPITHELIAL CELLS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/612153 [patent_app_country] => US [patent_app_date] => 2020-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612153
CULTURE CONTAINER FOR CULTURING EPITHELIAL CELLS AND USE THEREOF Mar 22, 2020 Issued
Array ( [id] => 17444166 [patent_doc_number] => 20220064671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES [patent_app_type] => utility [patent_app_number] => 17/423737 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 139778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 331 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423737 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/423737
METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES Jan 16, 2020 Abandoned
Array ( [id] => 19909357 [patent_doc_number] => 12285546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-29 [patent_title] => Animal fat-derived extracellular matrix, and preservation solution of animal fat-derived extracellular matrix [patent_app_type] => utility [patent_app_number] => 17/594602 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 1988 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594602 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594602
Animal fat-derived extracellular matrix, and preservation solution of animal fat-derived extracellular matrix Nov 20, 2019 Issued
Array ( [id] => 17214791 [patent_doc_number] => 20210348128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => MAKING AND USING CARDIOPOIETIC CELLS [patent_app_type] => utility [patent_app_number] => 17/278380 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278380 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/278380
Making and using cardiopoietic cells Sep 26, 2019 Issued
Menu